Submitted by Anonymous (not verified) on 30 November 2023 - 8:53
Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Prostatic Neoplasms, Date of authorisation: 24/07/2023, Revision: 1, Status: Authorised
Source: